Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
Neurodegenerative diseases are, according to recent studies, one of the main causes of disability and death worldwide. Interest in molecular genetics has started to experience exponential growth thanks to numerous advancements in technology, shifts in the understanding of the disease as a phenomenon, and the change in the perspective regarding gene editing and the advantages of this action. The aim of this paper is to analyze the newest approaches in genetics and molecular sciences regarding four of the most important neurodegenerative disorders: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. We intend through this review to focus on the newest treatment, diagnosis, and predictions regarding this large group of diseases, in order to obtain a more accurate analysis and to identify the emerging signs that could lead to a better outcome in order to increase both the quality and the life span of the patient. Moreover, this review could provide evidence of future possible novel therapies that target the specific genes and that could be useful to be taken into consideration when the classical approaches fail to shed light.
Топ-30
Журналы
|
1
2
3
|
|
|
Cureus
3 публикации, 4.84%
|
|
|
bioRxiv
2 публикации, 3.23%
|
|
|
Ageing Research Reviews
2 публикации, 3.23%
|
|
|
Frontiers in Neuroscience
2 публикации, 3.23%
|
|
|
International Journal of Nanomedicine
2 публикации, 3.23%
|
|
|
European Journal of Pharmacology
2 публикации, 3.23%
|
|
|
Clinical and Translational Medicine
1 публикация, 1.61%
|
|
|
Molecular Neurobiology
1 публикация, 1.61%
|
|
|
Acta Pharmaceutica Sinica B
1 публикация, 1.61%
|
|
|
F1000Research
1 публикация, 1.61%
|
|
|
Israel Journal of Chemistry
1 публикация, 1.61%
|
|
|
Toxicology Reports
1 публикация, 1.61%
|
|
|
Frontiers in Pharmacology
1 публикация, 1.61%
|
|
|
Medicinal Chemistry Research
1 публикация, 1.61%
|
|
|
Progress in Biophysics and Molecular Biology
1 публикация, 1.61%
|
|
|
Phytomedicine Plus
1 публикация, 1.61%
|
|
|
ChemistrySelect
1 публикация, 1.61%
|
|
|
Current Treatment Options in Neurology
1 публикация, 1.61%
|
|
|
Journal of Ethnopharmacology
1 публикация, 1.61%
|
|
|
Journal of Computer-Aided Molecular Design
1 публикация, 1.61%
|
|
|
EBioMedicine
1 публикация, 1.61%
|
|
|
Advances in Medical Education, Research, and Ethics
1 публикация, 1.61%
|
|
|
Nutritional Neuroscience
1 публикация, 1.61%
|
|
|
Journal of Molecular Neuroscience
1 публикация, 1.61%
|
|
|
The Egyptian Journal of Internal Medicine
1 публикация, 1.61%
|
|
|
Human Genetics
1 публикация, 1.61%
|
|
|
Cell Proliferation
1 публикация, 1.61%
|
|
|
Inflammopharmacology
1 публикация, 1.61%
|
|
|
Molecular Biology Reports
1 публикация, 1.61%
|
|
|
1
2
3
|
Издатели
|
2
4
6
8
10
12
14
16
18
|
|
|
Elsevier
18 публикаций, 29.03%
|
|
|
Springer Nature
17 публикаций, 27.42%
|
|
|
Wiley
5 публикаций, 8.06%
|
|
|
Taylor & Francis
5 публикаций, 8.06%
|
|
|
Frontiers Media S.A.
4 публикации, 6.45%
|
|
|
openRxiv
2 публикации, 3.23%
|
|
|
American Chemical Society (ACS)
2 публикации, 3.23%
|
|
|
Bentham Science Publishers Ltd.
2 публикации, 3.23%
|
|
|
F1000 Research
1 публикация, 1.61%
|
|
|
IGI Global
1 публикация, 1.61%
|
|
|
IntechOpen
1 публикация, 1.61%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 публикация, 1.61%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.61%
|
|
|
IOP Publishing
1 публикация, 1.61%
|
|
|
IOS Press
1 публикация, 1.61%
|
|
|
2
4
6
8
10
12
14
16
18
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.